China Approves First Monkeypox Virus Test Kit for Market Entry
Background
The National Medical Products Administration (NMPA) of China has granted market entry approval to the first monkeypox virus nucleic acid test kit developed by a domestic company.
The test kit, developed by Sansure Biotech, is based on real-time fluorescent PCR technology and can detect the monkeypox virus with high accuracy.
Significance
This approval marks a significant step in the fight against the monkeypox virus in China.
The availability of a reliable and accurate test kit will enable healthcare professionals to quickly identify and isolate infected individuals, preventing further spread of the virus.
Features of the Test Kit
- High sensitivity and specificity
- Rapid detection within 1 hour
- Easy to use
- Suitable for use in various settings, including hospitals, clinics, and laboratories
Global Response
The World Health Organization (WHO) has declared monkeypox a global health emergency and has called on countries to step up their surveillance and testing efforts.
Several other countries have also approved monkeypox virus test kits for market entry, including the United States, the United Kingdom, and the European Union.
Additional Information
For more information on monkeypox virus and the approved test kit:
